
Shinbiosis provides bacterial liquid therapies to support gut health. It uses proprietary Nano GAS technology and fecal microbiota transplantation to deliver its products. The company operates as a biotech R&D business focused on microbiota applications for healthcare providers. Positioned in the B2B space, Shinbiosis aims to scale regenerative microbiome therapies across multiple clinical applications.

Shinbiosis provides bacterial liquid therapies to support gut health. It uses proprietary Nano GAS technology and fecal microbiota transplantation to deliver its products. The company operates as a biotech R&D business focused on microbiota applications for healthcare providers. Positioned in the B2B space, Shinbiosis aims to scale regenerative microbiome therapies across multiple clinical applications.